NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 129 filers reported holding NOVOCURE LTD in Q4 2017. The put-call ratio across all filers is 0.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $310,000 | +54.2% | 1,397 | -8.1% | 0.01% | +80.0% |
| Q1 2021 | $201,000 | +200.0% | 1,520 | +153.3% | 0.01% | +66.7% |
| Q3 2020 | $67,000 | -38.5% | 600 | -67.3% | 0.00% | -50.0% |
| Q2 2020 | $109,000 | -90.3% | 1,836 | -92.2% | 0.01% | -90.5% |
| Q1 2019 | $1,127,000 | +33.5% | 23,403 | -7.2% | 0.06% | +10.5% |
| Q4 2018 | $844,000 | -38.9% | 25,215 | -4.4% | 0.06% | -28.8% |
| Q3 2018 | $1,382,000 | +65.7% | 26,369 | -1.0% | 0.08% | +50.9% |
| Q2 2018 | $834,000 | +56.2% | 26,634 | +8.7% | 0.05% | +35.9% |
| Q1 2018 | $534,000 | -0.7% | 24,513 | -8.0% | 0.04% | -9.3% |
| Q4 2017 | $538,000 | +186.2% | 26,634 | +181.5% | 0.04% | +152.9% |
| Q3 2017 | $188,000 | -44.2% | 9,461 | -76.0% | 0.02% | -51.4% |
| Q3 2016 | $337,000 | – | 39,483 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |